Article Versions Notes

Wang P, Lan Q, Huang Q, Zhang R, Zhang S, Yang L, Song Y, Wang T, Ma G, Liu X, et al. Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation. Biology. 2024; 13(8):597. https://doi.org/10.3390/biology13080597

Wang, Pengyu, Qing Lan, Qi Huang, Ruyi Zhang, Shuo Zhang, Leiming Yang, Yan Song, Tong Wang, Guandi Ma, Xiufen Liu, and et al. 2024. "Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation" Biology 13, no. 8: 597. https://doi.org/10.3390/biology13080597

Wang, P., Lan, Q., Huang, Q., Zhang, R., Zhang, S., Yang, L., Song, Y., Wang, T., Ma, G., Liu, X., Guo, X., Zhang, Y., & Liu, C. (2024). Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation. Biology, 13(8), 597. https://doi.org/10.3390/biology13080597